Insider buying
~$114K50K sh @ $2.28
Traded Dec 11, 2024 · filed 3 days later
A major shareholder of Adc Therapeutics paid $114K out of pocket for Adc Therapeutics shares. It was the first purchase in over a year.
Ask OQRO reads the filings behind this page and answers in plain words, with a link to each source.
Ask OQRO is part of OQRO Pro. Everything else on OQRO is free.
Only to see which pages are hard to use, so we can fix them. Nothing is used for ads, and what you type stays hidden (Microsoft Clarity, PostHog). Privacy Policy
Traded Dec 11, 2024 · Filed Dec 14, 2024
A major shareholder of Adc Therapeutics paid $114K out of pocket for Adc Therapeutics shares. It was the first purchase in over a year.
Written from the filing's own figures. OQRO describes what was reported and never tells you what to buy or sell.
open market purchase
Code P — open-market or private purchase
~$114,000
Shares × reported transaction price
$100K–$500K
+0.4%
Purchase shares ÷ estimated pre-transaction holdings, from the filing
None in 14 months of history
Confirmed open-market purchases by the same insider in the available history
No other insider purchases within 30 days
Distinct insiders at the same issuer with confirmed open-market purchases
34 days after results of Nov 7, 2024, 33 days before results of Jan 13, 2025
Results dates are the company's own 8-K (Item 2.02). Many companies only let insiders trade in a window after results
None found in footnotes
Only flagged when a footnote says so; never inferred
| After | Stock | S&P 500 | Difference |
|---|---|---|---|
| 7 days | −0.5% | −2.0% | +1.5% |
| 30 days | −11.0% | −2.3% | −8.7% |
| 90 days | −10.5% | −6.5% | −4.0% |
| 180 days | +69.0% | −0.7% | +69.7% |
| 365 days | +98.5% | +11.9% | +86.6% |
Past results only. Not a forecast.
Insider buying
Traded Dec 11, 2024 · filed 3 days later
A major shareholder of Adc Therapeutics paid $114K out of pocket for Adc Therapeutics shares. It was the first purchase in over a year.
Insider buying
Traded Dec 11, 2024 · filed 3 days later
A major shareholder of Adc Therapeutics paid $191K out of pocket for Adc Therapeutics shares. It was the first purchase in over a year.
Insider buying
Traded Dec 11, 2024 · filed 3 days later
A major shareholder of Adc Therapeutics paid $191K out of pocket for Adc Therapeutics shares. It was the first purchase in over a year.
Every dated public record OQRO holds about the company from 60 days before to 120 days after, oldest first. It shows what was going on; none of it is a stated reason for the trade.
Redmile Group, LLC, 10% owner's past purchases, 90 days after disclosure: 4 buys, median −10.4 pts vs S&P 500, beat it 1 of 4 times. Past results, not a forecast.